These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 35887698)
1. Translational Medicine: Towards Gene Therapy of Marfan Syndrome. Kallenbach K; Remes A; Müller OJ; Arif R; Zaradzki M; Wagner AH J Clin Med; 2022 Jul; 11(14):. PubMed ID: 35887698 [TBL] [Abstract][Full Text] [Related]
2. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling. Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285 [TBL] [Abstract][Full Text] [Related]
3. miR-29b participates in early aneurysm development in Marfan syndrome. Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819 [TBL] [Abstract][Full Text] [Related]
4. Marfan syndrome: An eyesight of syndrome. Kumar A; Agarwal S Meta Gene; 2014 Dec; 2():96-105. PubMed ID: 25606393 [TBL] [Abstract][Full Text] [Related]
5. Cardiovascular characteristics in Marfan syndrome and their relation to the genotype. De Backer J Verh K Acad Geneeskd Belg; 2009; 71(6):335-71. PubMed ID: 20232788 [TBL] [Abstract][Full Text] [Related]
6. Optimising the mutation screening strategy in Marfan syndrome and identifying genotypes with more severe aortic involvement. Stengl R; Bors A; Ágg B; Pólos M; Matyas G; Molnár MJ; Fekete B; Csabán D; Andrikovics H; Merkely B; Radovits T; Szabolcs Z; Benke K Orphanet J Rare Dis; 2020 Oct; 15(1):290. PubMed ID: 33059708 [TBL] [Abstract][Full Text] [Related]
7. Indomethacin Prevents the Progression of Thoracic Aortic Aneurysm in Marfan Syndrome Mice. Guo G; Ott CE; Grünhagen J; Muñoz-García B; Pletschacher A; Kallenbach K; von Kodolitsch Y; Robinson PN Aorta (Stamford); 2013 Jun; 1(1):5-12. PubMed ID: 26798667 [TBL] [Abstract][Full Text] [Related]
9. Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome. Jespersen K; Li C; Batra R; Stephenson CA; Harding P; Sestak K; Foley RT; Greene H; Meisinger T; Cook JR; Baxter BT; Xiong W J Immunol Res; 2022; 2022():7538649. PubMed ID: 35211631 [TBL] [Abstract][Full Text] [Related]
10. Mutation analysis of the FBN1 gene in a cohort of patients with Marfan Syndrome: A 10-year single center experience. Mannucci L; Luciano S; Salehi LB; Gigante L; Conte C; Longo G; Ferradini V; Piumelli N; Brancati F; Ruvolo G; Novelli G; Sangiuolo F Clin Chim Acta; 2020 Feb; 501():154-164. PubMed ID: 31730815 [TBL] [Abstract][Full Text] [Related]
11. Mutations of FBN1 and genotype-phenotype correlations in Marfan syndrome and related fibrillinopathies. Robinson PN; Booms P; Katzke S; Ladewig M; Neumann L; Palz M; Pregla R; Tiecke F; Rosenberg T Hum Mutat; 2002 Sep; 20(3):153-61. PubMed ID: 12203987 [TBL] [Abstract][Full Text] [Related]
12. Dural ectasia and FBN1 mutation screening of 40 patients with Marfan syndrome and related disorders: role of dural ectasia for the diagnosis. Attanasio M; Pratelli E; Porciani MC; Evangelisti L; Torricelli E; Pellicanò G; Abbate R; Gensini GF; Pepe G Eur J Med Genet; 2013 Jul; 56(7):356-60. PubMed ID: 23684891 [TBL] [Abstract][Full Text] [Related]
13. Genotype and phenotype analysis of 171 patients referred for molecular study of the fibrillin-1 gene FBN1 because of suspected Marfan syndrome. Loeys B; Nuytinck L; Delvaux I; De Bie S; De Paepe A Arch Intern Med; 2001 Nov; 161(20):2447-54. PubMed ID: 11700157 [TBL] [Abstract][Full Text] [Related]
14. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome. Chung AW; Au Yeung K; Sandor GG; Judge DP; Dietz HC; van Breemen C Circ Res; 2007 Aug; 101(5):512-22. PubMed ID: 17641224 [TBL] [Abstract][Full Text] [Related]
15. Recent molecular biological progress in Marfan syndrome and Marfan-associated disorders. Gao LG; Luo F; Hui RT; Zhou XL Ageing Res Rev; 2010 Jul; 9(3):363-8. PubMed ID: 19772952 [TBL] [Abstract][Full Text] [Related]
18. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice. Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322 [TBL] [Abstract][Full Text] [Related]
19. Circulating transforming growth factor-beta in Marfan syndrome. Matt P; Schoenhoff F; Habashi J; Holm T; Van Erp C; Loch D; Carlson OD; Griswold BF; Fu Q; De Backer J; Loeys B; Huso DL; McDonnell NB; Van Eyk JE; Dietz HC; Circulation; 2009 Aug; 120(6):526-32. PubMed ID: 19635970 [TBL] [Abstract][Full Text] [Related]
20. Co-existence of Marfan syndrome and systemic sclerosis: A case report and a hypothesis suggesting a common link. Yap WF; Chong HC Int J Rheum Dis; 2020 Nov; 23(11):1568-1573. PubMed ID: 32969582 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]